These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27616206)

  • 1. Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Bhardwaj G; Dörr M; Sappa PK; Ameling S; Dhople V; Steil L; Klingel K; Empen K; Beug D; Völker U; Felix SB; Hammer E
    J Proteomics; 2017 Jan; 150():121-129. PubMed ID: 27616206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Ameling S; Herda LR; Hammer E; Steil L; Teumer A; Trimpert C; Dörr M; Kroemer HK; Klingel K; Kandolf R; Völker U; Felix SB
    Eur Heart J; 2013 Mar; 34(9):666-75. PubMed ID: 23100283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution.
    Ameling S; Bhardwaj G; Hammer E; Beug D; Steil L; Reinke Y; Weitmann K; Grube M; Trimpert C; Klingel K; Kandolf R; Hoffmann W; Nauck M; Dörr M; Empen K; Felix SB; Völker U
    Basic Res Cardiol; 2016 Sep; 111(5):53. PubMed ID: 27412778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy.
    Kallwellis-Opara A; Staudt A; Trimpert C; Noutsias M; Kühl U; Pauschinger M; Schultheiss HP; Grube M; Böhm M; Baumann G; Völker U; Kroemer HK; Felix SB
    J Mol Med (Berl); 2007 Dec; 85(12):1429-35. PubMed ID: 17924085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
    Dandel M; Wallukat G; Englert A; Hetzer R
    Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.
    Bulut D; Creutzenberg G; Mügge A
    Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies.
    Hammer E; Goritzka M; Ameling S; Darm K; Steil L; Klingel K; Trimpert C; Herda LR; Dörr M; Kroemer HK; Kandolf R; Staudt A; Felix SB; Völker U
    J Proteome Res; 2011 May; 10(5):2161-71. PubMed ID: 21417265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
    Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB
    Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB; Staudt A
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.
    Yoshikawa T; Baba A; Akaishi M; Wakabayashi Y; Monkawa T; Kitakaze M; Izumi T; Tomoike H
    J Clin Apher; 2016 Dec; 31(6):535-544. PubMed ID: 26801483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
    Ohlow MA; Brunelli M; Schreiber M; Lauer B
    J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.
    Felix SB; Staudt A; Dörffel WV; Stangl V; Merkel K; Pohl M; Döcke WD; Morgera S; Neumayer HH; Wernecke KD; Wallukat G; Stangl K; Baumann G
    J Am Coll Cardiol; 2000 May; 35(6):1590-8. PubMed ID: 10807465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption in dilated cardiomyopathy.
    Staudt A; Felix SB
    Transfus Apher Sci; 2007 Oct; 37(2):187-90. PubMed ID: 18036989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.
    Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB
    J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoadsorption in patients with dilated cardiomyopathy.
    Herda LR; Felix SB; Staudt A
    Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proteome profiling in canine idiopathic dilated cardiomyopathy using TMT-based quantitative proteomics approach.
    Bilić P; Guillemin N; Kovačević A; Beer Ljubić B; Jović I; Galan A; Eckersall PD; Burchmore R; Mrljak V
    J Proteomics; 2018 May; 179():110-121. PubMed ID: 29530679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadsorption in dilated cardiomyopathy.
    Dörffel WV; Wallukat G; Baumann G; Felix SB
    Ther Apher; 2000 Jun; 4(3):235-8. PubMed ID: 10910026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.